Australia markets closed

Gyre Therapeutics Inc. (L9S.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
10.00+0.15 (+1.52%)
At close: 09:53PM CEST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
Assets
Current assets
Cash
Cash and cash equivalents
33,509
25,175
26,089
Other short-term investments
-
10,597
389.0745
Total cash
33,509
25,175
26,478
Net receivables
15,204
15,738
10,050
Inventory
4,281
6,122
5,720
Other current assets
1,045
843
-
Total current assets
57,221
49,653
44,852
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
28,042
22,373
20,830
Accumulated depreciation
-4,265
-3,998
-3,487
Net property, plant and equipment
23,777
18,375
17,343
Equity and other investments
23,431
7,394
0
Intangible assets
1,698
1,856
20,764
Other long-term assets
995
3,394
-
Total non-current assets
59,318
35,100
40,003
Total assets
116,539
84,753
84,854
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
355
122
251.0158
Taxes payable
5,054
2,101
-
Accrued liabilities
11,247
8,596
-
Deferred revenues
79
167
-
Total current liabilities
20,047
12,242
10,296
Non-current liabilities
Deferred revenues
213
118
891.5769
Other long-term liabilities
49
55
-
Total non-current liabilities
82,543
294
1,634
Total liabilities
102,590
12,536
11,930
Stockholders' equity
Common stock
77
64
9,620
Retained earnings
-85,538
7,395
23,079
Accumulated other comprehensive income
1,454
2,268
40,225
Total stockholders' equity
-15,828
42,522
72,924
Total liabilities and stockholders' equity
116,539
84,753
84,854